Volume 26, Issue 6
Frontispiece
Free Access

Frontispiece: Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications

Rongzhen Wu

Rongzhen Wu

Department of Chemistry, Southern University of Science and Technology of China, Shenzhen, 518055 P. R. China

Search for more papers by this author
Hongyu Chen

Hongyu Chen

Department of Biology, Southern University of Science and Technology of China, Shenzhen, 518055 P. R. China

Search for more papers by this author
Dr. Ninghui Chang

Dr. Ninghui Chang

Department of Chemistry, School of Science, Northwestern Polytechnical University, Xi'an, 710072 P. R. China

Search for more papers by this author
Yuzhi Xu

Yuzhi Xu

School of Materials Science and Engineering, South China University of Technology, Guangzhou, 510006 P. R. China

Search for more papers by this author
Prof. Dr. Jiao Jiao

Corresponding Author

Prof. Dr. Jiao Jiao

Department of Chemistry, School of Science, Xi'an Key Laboratory of Sustainable Energy Materials Chemistry, Xi'an Jiaotong University, Xi'an, 710049 P. R. China

Search for more papers by this author
Prof. Dr. Hailong Zhang

Corresponding Author

Prof. Dr. Hailong Zhang

School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061 P. R. China

Search for more papers by this author
First published: 30 January 2020

Graphical Abstract

Bryostatins, a class of naturally occurring macrocyclic lactones with eleven chiral centers, which were isolated from marine invertebrates, turned out as promising candidates for medicinal applications, including AIDS, Alzheimer's disease, and cancer. The ongoing work towards the total synthesis of bryostatins and structural analogues (bryologs) as well as the biomedical application of these compounds is summarized in the Review by J. Jiao, H. Zhang et al. on page 1166 ff.